Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality
worldwide and a leading cause of death in cirrhosis. The prognosis in HCC is poor, with …

Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …

Liver transplantation offers live-saving therapy for patients with complications of cirrhosis
and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and …

Importance Several factors are associated with increased hepatocellular carcinoma (HCC)
recurrence after liver transplantation (LT), but no reliable risk score has been established to …

Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

Background & Aims United Network of Organ Sharing (UNOS) has adopted uniform criteria
for downstaging (UNOS-DS) of hepatocellular carcinoma (HCC) before liver transplantation …

Simple Summary Liver cancer is a major health problem worldwide, and its early detection
and management are imperative for improving patient outcomes. Biomarkers have great …

Hepatocellular carcinoma (HCC) is an increasingly common indication for liver
transplantation (LT) in the United States and in many parts of the world. In the last decade …

Hepatocellular carcinoma (HCC) represents the third cause of cancer death in men
worldwide, and its increasing incidence can be explained by the increasing occurrence of …

In patients with HCC awaiting liver transplantation (LT), there is a need to identify
biomarkers that are superior to AFP in predicting prognosis. AFP-L3 and des-gamma …